Literature DB >> 32711179

Engagement of Posthemorrhagic Shock Mesenteric Lymph on CD4+ T Lymphocytes In Vivo and In Vitro.

Li-Na Jiang1, Ya-Li Mi2, Li-Min Zhang1, Gui-Qing Liu1, Huai-Huai Wang1, Zi-Gang Zhao3, Chun-Yu Niu4.   

Abstract

BACKGROUND: Immune dysfunction is associated with posthemorrhagic shock mesenteric lymph (PHSML) return. To determine the proliferation and cytokine production capacity of CD4+ T lymphocytes, the effect of PHSML drainage on spleen CD4+ T lymphocytes in a mouse model of hemorrhagic shock was assessed.
METHODS: The normal spleen CD4+ T lymphocytes were in vitro incubated with either drained normal mesenteric lymph (NML), PHSML during hypotension (PHSML-H), or PHSML from 0 h to 3 h after resuscitation (PHSML-R) to verify direct proliferation effects of PHSML.
RESULTS: Hemorrhagic shock led to reduction of proliferation and mRNA expression of interleukin 2 (IL-2) and IL-2 receptor in CD4+ T lymphocytes and to decrease in IL-2 and interferon γ (IFN-γ) levels in supernatants. In contrast, the interleukin-4 levels were increased. These effects were reversed by PHSML drainage. Moreover, NML incubation promoted CD4+ T lymphocyte proliferation, whereas both PHSML-H and PHSML-R treatment had a biphasic effects on CD4+ T lymphocyte proliferation, exhibiting an enhanced effect at early stages and an inhibitory effect at later stages. Compared with NML, PHSML-H increased IL-2 expression at 12 h, but decreased expression of both IL-2 and IFN-γ at 24 h. By contrast, PHSML-R induced significant increases in IL-2 and IFN-γ levels at 24 h. Interleukin-4 expression in CD4+ T lymphocytes was reduced at 12 h, but augmented at 24 h after incubation with either PHSML-H or PHSML-R.
CONCLUSIONS: The results indicate that PHSML has a direct inhibitory effect on CD4+ T lymphocyte proliferation that induces an inflammatory response, which is associated with cellular immune dysfunction.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4(+) T lymphocytes; Hemorrhagic shock; Immune dysfunction; Inflammation; Mesenteric lymph

Year:  2020        PMID: 32711179     DOI: 10.1016/j.jss.2020.06.044

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Stellate Ganglion Block Improves the Proliferation and Function of Splenic CD4 + T Cells Through Inhibition of Posthemorrhagic Shock Mesenteric Lymph-Mediated Autophagy.

Authors:  Ying Li; Hui-Bo Du; Li-Na Jiang; Chen Wang; Meng Yin; Li-Min Zhang; Hong Zhang; Zhen-Ao Zhao; Zhan-Kuang Liu; Chun-Yu Niu; Zi-Gang Zhao
Journal:  Inflammation       Date:  2021-09-17       Impact factor: 4.092

2.  TLR2/TLR4-Enhanced TIPE2 Expression Is Involved in Post-Hemorrhagic Shock Mesenteric Lymph-Induced Activation of CD4+T Cells.

Authors:  Hui-Bo Du; Sun-Ban Jiang; Zhen-Ao Zhao; Hong Zhang; Li-Min Zhang; Zhao Wang; Ya-Xiong Guo; Jia-Yi Zhai; Peng Wang; Zi-Gang Zhao; Chun-Yu Niu; Li-Na Jiang
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

3.  Estradiol-induced inhibition of endoplasmic reticulum stress normalizes splenic CD4 + T lymphocytes following hemorrhagic shock.

Authors:  Peng Wang; Li-Na Jiang; Chen Wang; Ying Li; Meng Yin; Hui-Bo Du; Hong Zhang; Ze-Hua Fan; Yan-Xu Liu; Meng Zhao; An-Ling Kang; Ding-Ya Feng; Shu-Guang Li; Chun-Yu Niu; Zi-Gang Zhao
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.379

4.  Hydroxyethyl Starch Improves the Prognosis of Rats with Traumatic Shock via Activation of the ERK Signaling Pathway in Lymphocytes.

Authors:  Yun Liu; Jian Lu; Caifu Dong; Limin Zhu; Li Zhou; Kai Zhu
Journal:  Comput Math Methods Med       Date:  2022-02-08       Impact factor: 2.238

5.  Controlled Hemorrhage Sensitizes Angiotensin II-Elicited Hypertension through Activation of the Brain Renin-Angiotensin System Independently of Endoplasmic Reticulum Stress.

Authors:  Guo-Biao Wu; Hui-Bo Du; Jia-Yi Zhai; Si Sun; Jun-Ling Cui; Yang Zhang; Zhen-Ao Zhao; Jian-Liang Wu; Alan Kim Johnson; Baojian Xue; Zi-Gang Zhao; Geng-Shen Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-01-13       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.